Monthly Archives: February 2020

2019 FDA Advanced Personalized Medicine Products Tackle Root Causes of Rare Diseases, Provide Expanded Options for Cancer Patients, and Help Target Stakeholder Therapies, PMC Report Says

[ad_1] Personalized Medicine at the FDA: The Scope and Significance of Advances in 2019 defines personalized medicine as an area “in which physicians use diagnostic tests to determine which medical treatments will work best for each patient or use medical interventions to alter molecular, often genetic, mechanisms that cause disease …

Read More »